REVISYON

· Edinburgh Biosciences Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REVISYON, covering 2025-11-24 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study To Assess A Novel Form Of Cataract Treatment Using The Non-Invasive REVISYON Proof-Of-Concept Device [NA]